HomeNews

News

KRd Improves Development in Newly Recognized Sufferers With Myeloma

Amongst sufferers who have been newly identified with a number of myeloma, Kyprolis (carfilzomib) plus Revlimid (lenalidomide) and dexamethasone (KRd) was related...

Actual-Time Textual content Instrument Tracks High quality of Life in Myeloma Care

On the 2025 ASH Annual Assembly, Dr. James Berenson, of the Berenson Most cancers Heart, introduced new findings on a text-based platform...

Odronextamab Plus CHOP Reveals Early Efficacy in DLBCL

Amog sufferers with beforehand untreated diffuse massive B-cell lymphoma (DLBCL), therapy with the CD20 and CD3 bispecific antibody odronextamab has been related...

Elrexfio Maintains Responses in Aged, Frail Sufferers With A number of Myeloma

Amongst sufferers with relapsed/refractory a number of myeloma, a central evaluation of real-world Elrexfio (elranatamab-bcmm) was related to shorter occasions till illness...

Fastened Length Venclexta Combos Delay Development in CLL Equally to Imbruvica

Amongst beforehand untreated sufferers with continual lymphocytic leukemia (CLL), fixed-duration remedy with Venclexta (venetoclax) plus Gazyva (obinutuzumab) or Imbruvica (ibrutinib) have been...

Hot Topics